DEF 14A: Aadi Bioscience Sets Date for 2024 Annual Stockholders Meeting

Aadi Bioscience will hold its 2024 Annual Meeting of Stockholders virtually on June 11, 2024, to vote on director elections, executive compensation, and auditor ratification.

Summary

• Aadi Bioscience, Inc. will hold its 2024 Annual Meeting of Stockholders online on June 11, 2024.
• Stockholders of record as of April 18, 2024, are entitled to vote at the meeting.
• The agenda includes the election of two Class I directors, an advisory vote on executive compensation, and the ratification of BDO USA LLP as the company's independent registered accounting firm for the fiscal year ending December 31, 2024.
• The Board recommends voting 'FOR' the election of directors and the ratification of the accounting firm, and 'FOR' the advisory vote on executive compensation.
• The proxy statement and annual report are available online at www.proxyvote.com and were first made available on or about April 26, 2024.
• The board consists of nine members divided into three staggered classes.
• The Board has determined that seven of the nine directors are independent.
• The company has established Audit, Compensation, and Nominating and Corporate Governance Committees.
• The company's insider trading policy prohibits hedging and pledging of company securities by directors, officers, employees, consultants, contractors, or advisors.
• The company has adopted a director compensation policy that provides for cash compensation and equity awards to non-employee directors.
• The company provides annual incentive compensation to its named executive under its Senior Executive Cash Incentive Bonus Plan.
• The company offers a 401(k) plan to eligible employees, including named executive officers, with matching contributions up to 4% of eligible earnings.
• As of April 18, 2024, 24,554,205 shares of common stock were outstanding.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. The information is presented in a factual manner, and the overall sentiment is moderately positive due to the routine nature of the items being addressed.

Positives

• The company has a majority-independent board, promoting strong corporate governance.
• The company has established Audit, Compensation, and Nominating and Corporate Governance Committees.
• The company offers a 401(k) plan to eligible employees, including named executive officers, with matching contributions up to 4% of eligible earnings.
• The company has adopted a director compensation policy that provides for cash compensation and equity awards to non-employee directors.

Risks

• The proxy statement references risks detailed in the company's annual and quarterly reports filed with the SEC, including the Annual Report on Form 10-K for the fiscal year ended December 31, 2023.
• These risks include those relating to the company's financial condition, development and commercialization activities, operations, strategic direction, and intellectual property.

Future Outlook

The document outlines the agenda for the upcoming annual meeting and provides information on corporate governance and executive compensation, but does not contain specific forward-looking statements or guidance regarding future financial performance.

Industry Context

This document is a standard proxy statement, providing information to shareholders in advance of the annual meeting. It covers typical items such as director elections, executive compensation, and auditor ratification, which are common across publicly traded companies.

Management Changes

Related Party Transactions

• Entities affiliated with board members and executive officers participated in a private placement in September 2022.

Stakeholder Impact

• Shareholders are asked to vote on key proposals that will influence the company's direction and governance.
• The outcome of the votes will impact the composition of the board and the approval of executive compensation.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• Attend the virtual Annual Meeting on June 11, 2024.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Board of Directors, Executive Compensation, Director Election, BDO USA LLP, Corporate Governance, Aadi Bioscience